Literature DB >> 25742452

Timing is everything for compassionate use of delamanid.

Clifton E Barry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25742452      PMCID： PMC6380361          DOI： 10.1038/nm.3823

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.

Authors:  Rokeya Tasneen; Si-Yang Li; Charles A Peloquin; Dinesh Taylor; Kathy N Williams; Koen Andries; Khisimuzi E Mdluli; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Access sought to tuberculosis drug from nutraceutical company.

Authors:  Karl Gruber
Journal:  Nat Med       Date:  2015-02-02       Impact factor: 53.440

3.  ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.

Authors:  Susanna Esposito; Lia D'Ambrosio; Marina Tadolini; H Simon Schaaf; Josè Caminero Luna; Ben Marais; Rosella Centis; Masoud Dara; Alberto Matteelli; Francesco Blasi; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2014-05-15       Impact factor: 16.671

4.  Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.

Authors:  Lorenzo Guglielmetti; Damien Le Dû; Mathilde Jachym; Benoît Henry; Diane Martin; Eric Caumes; Nicolas Veziris; Nathalie Métivier; Jérôme Robert
Journal:  Clin Infect Dis       Date:  2014-10-15       Impact factor: 9.079

5.  Delamanid for multidrug-resistant pulmonary tuberculosis.

Authors:  Maria Tarcela Gler; Vija Skripconoka; Epifanio Sanchez-Garavito; Heping Xiao; Jose L Cabrera-Rivero; Dante E Vargas-Vasquez; Mengqiu Gao; Mohamed Awad; Seung-Kyu Park; Tae Sun Shim; Gee Young Suh; Manfred Danilovits; Hideo Ogata; Anu Kurve; Joon Chang; Katsuhiro Suzuki; Thelma Tupasi; Won-Jung Koh; Barbara Seaworth; Lawrence J Geiter; Charles D Wells
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245
  5 in total
  6 in total

1.  Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis.

Authors:  Chao Gao; Cuiting Peng; Yaojie Shi; Xinyu You; Kai Ran; Lu Xiong; Ting-Hong Ye; Lidan Zhang; Ningyu Wang; Yongxia Zhu; Kun Liu; Weiqiong Zuo; Luoting Yu; Yuquan Wei
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

Review 2.  Current strategies to treat tuberculosis.

Authors:  Anthony T Podany; Susan Swindells
Journal:  F1000Res       Date:  2016-10-26

3.  Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.

Authors:  Katharigatta Narayanaswamy Venugopala; Sandeep Chandrashekharappa; Melendhran Pillay; Hassan H Abdallah; Fawzi M Mahomoodally; Subhrajyoti Bhandary; Deepak Chopra; Mahesh Attimarad; Bandar E Aldhubiab; Anroop B Nair; Nagaraja Sreeharsha; Mohamed A Morsy; Shinu Pottathil; Rashmi Venugopala; Bharti Odhav; Koleka Mlisana
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

4.  Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.

Authors:  Katharigatta N Venugopala; Christophe Tratrat; Melendhran Pillay; Fawzi M Mahomoodally; Subhrajyoti Bhandary; Deepak Chopra; Mohamed A Morsy; Michelyne Haroun; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Sandeep Chandrashekharappa; Osama I Alwassil; Bharti Odhav
Journal:  Antibiotics (Basel)       Date:  2019-12-03

Review 5.  Next-generation antimicrobials: from chemical biology to first-in-class drugs.

Authors:  Michelle Lay Teng Ang; Paul Murima; Kevin Pethe
Journal:  Arch Pharm Res       Date:  2015-08-11       Impact factor: 4.946

6.  In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis.

Authors:  Katharigatta N Venugopala; Christophe Tratrat; Melendhran Pillay; Sandeep Chandrashekharappa; Omar Husham Ahmed Al-Attraqchi; Bandar E Aldhubiab; Mahesh Attimarad; Osama I Alwassil; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Mohamed A Morsy; Michelyne Haroun; Hezekiel M Kumalo; Bharti Odhav; Koleka Mlisana
Journal:  Drug Des Devel Ther       Date:  2020-03-09       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.